 | • レポートコード：GIR-107A12498 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、81ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、顧みられない熱帯病診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。顧みられない熱帯病診断の種類別市場規模（従来型方法、分子/現代方法）、用途別市場規模（クリニック研究所、病院/クリニック、在宅ケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・顧みられない熱帯病診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Beckman Coulter/Danaher、Bio-Rad Laboratories, Inc.、Life Technology、Novartis Diagnostics., Ltd.、Ortho-Clinical Diagnostics、Premier Medical Corporation Ltd.、Siemens Healthcare、Wako Chemicals, Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：従来型方法、分子/現代方法 ・用途別分析2016年-2026年：クリニック研究所、病院/クリニック、在宅ケア ・顧みられない熱帯病診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・顧みられない熱帯病診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・顧みられない熱帯病診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・顧みられない熱帯病診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・顧みられない熱帯病診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Neglected Tropical Diseases Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Neglected Tropical Diseases Diagnosis size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Neglected Tropical Diseases Diagnosis market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Neglected Tropical Diseases Diagnosis market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Conventional Method
Molecular/Modern Method
Market segment by Application, can be divided into
Clinical Labs
Hospitals /Clinics
Home Healthcare
Market segment by players, this report covers
Abbott Laboratories
Beckman Coulter/Danaher
Bio-Rad Laboratories, Inc.
Life Technology
Novartis Diagnostics., Ltd.
Ortho-Clinical Diagnostics
Premier Medical Corporation Ltd.
Siemens Healthcare
Wako Chemicals, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Neglected Tropical Diseases Diagnosis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Neglected Tropical Diseases Diagnosis, with revenue, gross margin and global market share of Neglected Tropical Diseases Diagnosis from 2019 to 2021.
Chapter 3, the Neglected Tropical Diseases Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Neglected Tropical Diseases Diagnosis market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Neglected Tropical Diseases Diagnosis research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Neglected Tropical Diseases Diagnosis
1.2 Classification of Neglected Tropical Diseases Diagnosis by Type
1.2.1 Overview: Global Neglected Tropical Diseases Diagnosis Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Type in 2020
1.2.3 Conventional Method
1.2.4 Molecular/Modern Method
1.3 Global Neglected Tropical Diseases Diagnosis Market by Application
1.3.1 Overview: Global Neglected Tropical Diseases Diagnosis Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Clinical Labs
1.3.3 Hospitals /Clinics
1.3.4 Home Healthcare
1.4 Global Neglected Tropical Diseases Diagnosis Market Size & Forecast
1.5 Global Neglected Tropical Diseases Diagnosis Market Size and Forecast by Region
1.5.1 Global Neglected Tropical Diseases Diagnosis Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Neglected Tropical Diseases Diagnosis Market Size by Region, (2016-2021)
1.5.3 North America Neglected Tropical Diseases Diagnosis Market Size and Prospect (2016-2026)
1.5.4 Europe Neglected Tropical Diseases Diagnosis Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size and Prospect (2016-2026)
1.5.6 South America Neglected Tropical Diseases Diagnosis Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Neglected Tropical Diseases Diagnosis Market Drivers
1.6.2 Neglected Tropical Diseases Diagnosis Market Restraints
1.6.3 Neglected Tropical Diseases Diagnosis Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Neglected Tropical Diseases Diagnosis Product and Solutions
2.1.4 Abbott Laboratories Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Beckman Coulter/Danaher
2.2.1 Beckman Coulter/Danaher Details
2.2.2 Beckman Coulter/Danaher Major Business
2.2.3 Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Product and Solutions
2.2.4 Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Beckman Coulter/Danaher Recent Developments and Future Plans
2.3 Bio-Rad Laboratories, Inc.
2.3.1 Bio-Rad Laboratories, Inc. Details
2.3.2 Bio-Rad Laboratories, Inc. Major Business
2.3.3 Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Product and Solutions
2.3.4 Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
2.4 Life Technology
2.4.1 Life Technology Details
2.4.2 Life Technology Major Business
2.4.3 Life Technology Neglected Tropical Diseases Diagnosis Product and Solutions
2.4.4 Life Technology Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Life Technology Recent Developments and Future Plans
2.5 Novartis Diagnostics., Ltd.
2.5.1 Novartis Diagnostics., Ltd. Details
2.5.2 Novartis Diagnostics., Ltd. Major Business
2.5.3 Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Product and Solutions
2.5.4 Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Novartis Diagnostics., Ltd. Recent Developments and Future Plans
2.6 Ortho-Clinical Diagnostics
2.6.1 Ortho-Clinical Diagnostics Details
2.6.2 Ortho-Clinical Diagnostics Major Business
2.6.3 Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Product and Solutions
2.6.4 Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Ortho-Clinical Diagnostics Recent Developments and Future Plans
2.7 Premier Medical Corporation Ltd.
2.7.1 Premier Medical Corporation Ltd. Details
2.7.2 Premier Medical Corporation Ltd. Major Business
2.7.3 Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Product and Solutions
2.7.4 Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Premier Medical Corporation Ltd. Recent Developments and Future Plans
2.8 Siemens Healthcare
2.8.1 Siemens Healthcare Details
2.8.2 Siemens Healthcare Major Business
2.8.3 Siemens Healthcare Neglected Tropical Diseases Diagnosis Product and Solutions
2.8.4 Siemens Healthcare Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Siemens Healthcare Recent Developments and Future Plans
2.9 Wako Chemicals, Inc.
2.9.1 Wako Chemicals, Inc. Details
2.9.2 Wako Chemicals, Inc. Major Business
2.9.3 Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Product and Solutions
2.9.4 Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Wako Chemicals, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Neglected Tropical Diseases Diagnosis Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Neglected Tropical Diseases Diagnosis Players Market Share
3.2.2 Top 10 Neglected Tropical Diseases Diagnosis Players Market Share
3.2.3 Market Competition Trend
3.3 Neglected Tropical Diseases Diagnosis Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Neglected Tropical Diseases Diagnosis Revenue and Market Share by Type (2016-2021)
4.2 Global Neglected Tropical Diseases Diagnosis Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Application (2016-2021)
5.2 Neglected Tropical Diseases Diagnosis Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Neglected Tropical Diseases Diagnosis Revenue by Type (2016-2026)
6.2 North America Neglected Tropical Diseases Diagnosis Revenue by Application (2016-2026)
6.3 North America Neglected Tropical Diseases Diagnosis Market Size by Country
6.3.1 North America Neglected Tropical Diseases Diagnosis Revenue by Country (2016-2026)
6.3.2 United States Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
6.3.3 Canada Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
6.3.4 Mexico Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Neglected Tropical Diseases Diagnosis Revenue by Type (2016-2026)
7.2 Europe Neglected Tropical Diseases Diagnosis Revenue by Application (2016-2026)
7.3 Europe Neglected Tropical Diseases Diagnosis Market Size by Country
7.3.1 Europe Neglected Tropical Diseases Diagnosis Revenue by Country (2016-2026)
7.3.2 Germany Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
7.3.3 France Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
7.3.5 Russia Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
7.3.6 Italy Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue by Type (2016-2026)
8.2 Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue by Application (2016-2026)
8.3 Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size by Region
8.3.1 Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue by Region (2016-2026)
8.3.2 China Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
8.3.3 Japan Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
8.3.4 South Korea Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
8.3.5 India Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
8.3.7 Australia Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Neglected Tropical Diseases Diagnosis Revenue by Type (2016-2026)
9.2 South America Neglected Tropical Diseases Diagnosis Revenue by Application (2016-2026)
9.3 South America Neglected Tropical Diseases Diagnosis Market Size by Country
9.3.1 South America Neglected Tropical Diseases Diagnosis Revenue by Country (2016-2026)
9.3.2 Brazil Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
9.3.3 Argentina Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Neglected Tropical Diseases Diagnosis Revenue by Type (2016-2026)
10.2 Middle East & Africa Neglected Tropical Diseases Diagnosis Revenue by Application (2016-2026)
10.3 Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size by Country
10.3.1 Middle East & Africa Neglected Tropical Diseases Diagnosis Revenue by Country (2016-2026)
10.3.2 Turkey Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
10.3.4 UAE Neglected Tropical Diseases Diagnosis Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Neglected Tropical Diseases Diagnosis Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Neglected Tropical Diseases Diagnosis Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Neglected Tropical Diseases Diagnosis Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Neglected Tropical Diseases Diagnosis Revenue (USD Million) by Region (2016-2021)
Table 5. Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Neglected Tropical Diseases Diagnosis Product and Solutions
Table 9. Abbott Laboratories Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Beckman Coulter/Danaher Corporate Information, Head Office, and Major Competitors
Table 11. Beckman Coulter/Danaher Major Business
Table 12. Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Product and Solutions
Table 13. Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bio-Rad Laboratories, Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Bio-Rad Laboratories, Inc. Major Business
Table 16. Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Product and Solutions
Table 17. Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Life Technology Corporate Information, Head Office, and Major Competitors
Table 19. Life Technology Major Business
Table 20. Life Technology Neglected Tropical Diseases Diagnosis Product and Solutions
Table 21. Life Technology Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Novartis Diagnostics., Ltd. Corporate Information, Head Office, and Major Competitors
Table 23. Novartis Diagnostics., Ltd. Major Business
Table 24. Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Product and Solutions
Table 25. Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Ortho-Clinical Diagnostics Corporate Information, Head Office, and Major Competitors
Table 27. Ortho-Clinical Diagnostics Major Business
Table 28. Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Product and Solutions
Table 29. Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Premier Medical Corporation Ltd. Corporate Information, Head Office, and Major Competitors
Table 31. Premier Medical Corporation Ltd. Major Business
Table 32. Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Product and Solutions
Table 33. Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
Table 35. Siemens Healthcare Major Business
Table 36. Siemens Healthcare Neglected Tropical Diseases Diagnosis Product and Solutions
Table 37. Siemens Healthcare Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Wako Chemicals, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Wako Chemicals, Inc. Major Business
Table 40. Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Product and Solutions
Table 41. Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Neglected Tropical Diseases Diagnosis Revenue (USD Million) by Players (2019-2021)
Table 43. Global Neglected Tropical Diseases Diagnosis Revenue Share by Players (2019-2021)
Table 44. Breakdown of Neglected Tropical Diseases Diagnosis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Neglected Tropical Diseases Diagnosis Players Head Office, Products and Services Provided
Table 46. Neglected Tropical Diseases Diagnosis Mergers & Acquisitions in the Past Five Years
Table 47. Neglected Tropical Diseases Diagnosis New Entrants and Expansion Plans
Table 48. Global Neglected Tropical Diseases Diagnosis Revenue (USD Million) by Type (2016-2021)
Table 49. Global Neglected Tropical Diseases Diagnosis Revenue Share by Type (2016-2021)
Table 50. Global Neglected Tropical Diseases Diagnosis Revenue Forecast by Type (2021-2026)
Table 51. Global Neglected Tropical Diseases Diagnosis Revenue by Application (2016-2021)
Table 52. Global Neglected Tropical Diseases Diagnosis Revenue Forecast by Application (2021-2026)
Table 53. North America Neglected Tropical Diseases Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Neglected Tropical Diseases Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Neglected Tropical Diseases Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Neglected Tropical Diseases Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Neglected Tropical Diseases Diagnosis Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Neglected Tropical Diseases Diagnosis Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Neglected Tropical Diseases Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Neglected Tropical Diseases Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Neglected Tropical Diseases Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Neglected Tropical Diseases Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Neglected Tropical Diseases Diagnosis Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Neglected Tropical Diseases Diagnosis Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Neglected Tropical Diseases Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Neglected Tropical Diseases Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Neglected Tropical Diseases Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Neglected Tropical Diseases Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Neglected Tropical Diseases Diagnosis Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Neglected Tropical Diseases Diagnosis Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Neglected Tropical Diseases Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Neglected Tropical Diseases Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Neglected Tropical Diseases Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Neglected Tropical Diseases Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Neglected Tropical Diseases Diagnosis Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Neglected Tropical Diseases Diagnosis Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Neglected Tropical Diseases Diagnosis Picture
Figure 2. Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Type in 2020
Figure 3. Conventional Method
Figure 4. Molecular/Modern Method
Figure 5. Neglected Tropical Diseases Diagnosis Revenue Market Share by Application in 2020
Figure 6. Clinical Labs Picture
Figure 7. Hospitals /Clinics Picture
Figure 8. Home Healthcare Picture
Figure 9. Global Neglected Tropical Diseases Diagnosis Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Neglected Tropical Diseases Diagnosis Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Region (2016-2026)
Figure 12. Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Region in 2020
Figure 13. North America Neglected Tropical Diseases Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Neglected Tropical Diseases Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Neglected Tropical Diseases Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Neglected Tropical Diseases Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Neglected Tropical Diseases Diagnosis Market Drivers
Figure 19. Neglected Tropical Diseases Diagnosis Market Restraints
Figure 20. Neglected Tropical Diseases Diagnosis Market Trends
Figure 21. Abbott Laboratories Recent Developments and Future Plans
Figure 22. Beckman Coulter/Danaher Recent Developments and Future Plans
Figure 23. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Figure 24. Life Technology Recent Developments and Future Plans
Figure 25. Novartis Diagnostics., Ltd. Recent Developments and Future Plans
Figure 26. Ortho-Clinical Diagnostics Recent Developments and Future Plans
Figure 27. Premier Medical Corporation Ltd. Recent Developments and Future Plans
Figure 28. Siemens Healthcare Recent Developments and Future Plans
Figure 29. Wako Chemicals, Inc. Recent Developments and Future Plans
Figure 30. Global Neglected Tropical Diseases Diagnosis Revenue Share by Players in 2020
Figure 31. Neglected Tropical Diseases Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Neglected Tropical Diseases Diagnosis Revenue Market Share in 2020
Figure 33. Global Top 10 Players Neglected Tropical Diseases Diagnosis Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Neglected Tropical Diseases Diagnosis Revenue Share by Type in 2020
Figure 36. Global Neglected Tropical Diseases Diagnosis Market Share Forecast by Type (2021-2026)
Figure 37. Global Neglected Tropical Diseases Diagnosis Revenue Share by Application in 2020
Figure 38. Global Neglected Tropical Diseases Diagnosis Market Share Forecast by Application (2021-2026)
Figure 39. North America Neglected Tropical Diseases Diagnosis Sales Market Share by Type (2016-2026)
Figure 40. North America Neglected Tropical Diseases Diagnosis Sales Market Share by Application (2016-2026)
Figure 41. North America Neglected Tropical Diseases Diagnosis Revenue Market Share by Country (2016-2026)
Figure 42. United States Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Neglected Tropical Diseases Diagnosis Sales Market Share by Type (2016-2026)
Figure 46. Europe Neglected Tropical Diseases Diagnosis Sales Market Share by Application (2016-2026)
Figure 47. Europe Neglected Tropical Diseases Diagnosis Revenue Market Share by Country (2016-2026)
Figure 48. Germany Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Neglected Tropical Diseases Diagnosis Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Neglected Tropical Diseases Diagnosis Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue Market Share by Region (2016-2026)
Figure 56. China Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Neglected Tropical Diseases Diagnosis Sales Market Share by Type (2016-2026)
Figure 63. South America Neglected Tropical Diseases Diagnosis Sales Market Share by Application (2016-2026)
Figure 64. South America Neglected Tropical Diseases Diagnosis Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Neglected Tropical Diseases Diagnosis Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Neglected Tropical Diseases Diagnosis Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Neglected Tropical Diseases Diagnosis Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
世界の顧みられない熱帯病（NTD）治療市場予測（～2024年）：企業別、地域別、種類・用途別 Tropical diseases are diseases that are prevalent in or unique to tropical and subtropical regions. The diseases are less prevalent in temperate climates, due in part to the occurrence of a cold season, which controls the insect population by forcing hibernation. Scope of the Report: The global Negl…- 分子診断（MDx）の世界市場 2019年版：種類別（非侵襲的出生前検査（NIPT）、診断とともに、液体生検、その他の分子診断）、用途別（心血管、神経学、胃腸病学、感染症、腫瘍学、その他） Scope of the Report: The global Molecular Diagnosis (MDx) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China,…
- 世界の梅毒診断市場 2021：企業別、地域別、種類・用途別 The Syphilis Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界の非侵襲的がん診断市場 2021：企業別、地域別、種類・用途別 The Non-invasive Cancer Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の寄生虫症治療市場 2021：企業別、地域別、種類・用途別 The Parasitic Diseases Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …